Nvidia's $50M Leap into AI-Driven Drug Discovery

In this episode, we delve into Nvidia's significant investment of $50 million in Recursion, an AI drug discovery firm. We explore the potential impact of this collaboration on the future of pharmaceutical research and healthcare innovation. Invest in AI Box: }https://Republic.com/ai-box Get on the AI Box Waitlist: ⁠⁠}https://AIBox.ai/⁠⁠ AI Facebook Community Learn more about AI in Video Learn more about Open AI